STEMI Clinical Trial
Official title:
Erectile Dysfunction After Percutaneous Coronary Intervention Versus the Thrombolytic Therapy in Acute ST Elevation Myocardial Infarction
Erectile dysfunction is a common sexual problem affecting up to one-third of men throughout their life. It is now well recognized that risk factors for erectile dysfunction (ED) include the same risk factors as coronary artery disease, including smoking, dyslipidemia, diabetes, hypertension, lack of physical activity and obesity. We will investigate the effect of reperfusion strategies (primary angioplasty & therapeutic therapy) on the prevalence of erectile dysfunction after acute myocardial infarction. Erectile function will be evaluated using the international index of erectile function after 3 months of successful reperfusion treatment of acute myocardial infarction.
Myocardial infarction the term acute myocardial infarction(AMI) should be used when there is
evidence of myocardial injury (defined as an elevation of cardiac troponin values with at
least one value above the 99th percentile upper reference limit) with necrosis in a clinical
setting consistent with myocardial ischemia . Myocardial infarction is classified as either :
ST elevation acute myocardial infarction.* non-ST segment elevation acute myocardial
infarction. according to the electrocardiogram at the time of admission.
There are Two main treatment modalities for STEMI which are primary percutaneous coronary
intervention (PPCI) & thrombolytic treatment (TT).
- Erectile dysfunction (ED) is defined as the recurrent or persistent inability to achieve
and/or maintain an erection for satisfactory intercourse.Erectile function will be
evaluated using the international index of erectile function in the hospital to
characterize each patients sexual function before the acute myocardial infarction & 3
months after the event.
International Index of Erectile Function (IIEF-5) Questionnaire
1. How do you rate your confidence that could you get and keep an erection? 1)very low
2)low 3)moderate 4)high 5)very high
2. . When you had erections with sexual stimulation, how often were your erections hard
enough for penetration?
1) Almost never/never 2) A few times (much less than half the time) 3) Sometimes (about half
the time) 4) Most times (much more than half the time) 5) Almost always/always 3-During
sexual intercourse, how often were you able to maintain your erection after you had
penetrated (entered) your partner?
1. Almost never/never
2. A few times (much less than half the time)
3. Sometimes (about half the time)
4. Most times (much more than half the time)
5. Almost always/always 4- During sexual intercourse, how difficult was it to maintain your
erection to completion of intercourse?
1) Extremely difficult 2) Very difficult 3) Difficult 4) Slightly difficult 5) Not difficult
5- When you attempted sexual intercourse, how often was it satisfactory for you?
1. ) Almost never/never
2. A few times (much less than half the time)
3. Sometimes (about half the time)
4. Most times (much more than half the time)
5. Almost always/always the cases will be classified as:
- without ED (score greater than 25 points)
- mild ED (score 17 to 25),
- moderate ED (score 11 to 16)
- severe ED (score 10 points or less). No treatment for ED would applied within the
3-month period prior to the second IIEF evaluation for each patient
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02871622 -
BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
|
N/A | |
Completed |
NCT01452139 -
Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
|
Phase 2/Phase 3 | |
Completed |
NCT01325116 -
Delayed Educational Reminders in Acute Myocardial Infarction (MI)
|
N/A | |
Completed |
NCT01625104 -
Randomized Trial of a Quality Improvement Intervention to Decrease D2B Time in Primary PCI for AMI
|
N/A | |
Completed |
NCT04023266 -
A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI
|
Phase 2 | |
Completed |
NCT02170103 -
Microvascular Recovery With Ultrasound in Myocardial Infarction (MRUSMI) Post PCI Trial
|
N/A | |
Completed |
NCT03103620 -
Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
|
||
Not yet recruiting |
NCT05975567 -
Deploying Novel Imaging Modalities Towards a Three-dimensional (3D) CARDIOvascular PATHology
|
||
Completed |
NCT04017169 -
No Reflow Phenomenon Incidence and Predictors
|
||
Completed |
NCT03470441 -
A Study of Acute Myocardial Infarction Using FDY-5301
|
Phase 2 | |
Active, not recruiting |
NCT01433627 -
Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX
|
Phase 3 | |
Completed |
NCT01197742 -
Sweetheart-Register: Risk Management of Diabetics With Acute Myocardial Infarction
|
N/A | |
Terminated |
NCT03439150 -
Resistance STEMI Study
|
N/A | |
Recruiting |
NCT03998319 -
A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
|
Phase 3 | |
Not yet recruiting |
NCT05974930 -
Intravascular ULTRAsound-Guided PCI in Patients With ST-Elevation Myocardial Infarction
|
||
Active, not recruiting |
NCT03102723 -
Platelet Inhibition to Target Reperfusion Injury
|
Phase 2 | |
Completed |
NCT03930589 -
Remote Ischemic Conditioning in STEMI to Decrease Infarct Size
|
N/A | |
Not yet recruiting |
NCT04912167 -
The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction
|
Phase 3 | |
Completed |
NCT02942550 -
Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients
|
Phase 4 | |
Recruiting |
NCT02604394 -
Rheolytic Thrombectomy in Patients With Acute STEMI and Large Thrombus Burden
|
N/A |